Two Sigma Advisers
CLBT icon

Two Sigma Advisers’s Cellebrite CLBT Stock Holding History

Two Sigma Advisers’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-122,800
Closed -$2.21M – 436
2025
Q4 		$2.21M Sell
122,800
-67,400
-35% -$1.21M ﹤0.01% 1146
2025
Q3 		$3.52M Sell
190,200
-1,374,000
-88% -$21.6M 0.01% 875
2025
Q2 		$25M Sell
1,564,200
-175,600
-10% -$3.13M 0.05% 293
2025
Q1 		$33.8M Sell
1,739,800
-71,300
-4% -$1.5M 0.08% 236
2024
Q4 		$39.9M Buy
1,811,100
+470,000
+35% +$9.05M 0.09% 196
2024
Q3 		$22.6M Buy
1,341,100
+120,000
+10% +$1.78M 0.05% 297
2024
Q2 		$14.6M Buy
1,221,100
+52,200
+4% +$583K 0.03% 426
2024
Q1 		$13M Sell
1,168,900
-10,000
-0.8% -$102K 0.03% 450
2023
Q4 		$10.2M Buy
1,178,900
+827,700
+236% +$6.43M 0.02% 521
2023
Q3 		$2.69M Buy
351,200
+271,300
+340% +$2.04M 0.01% 1041
2023
Q2 		$575K Buy
+79,900
New +$466K ﹤0.01% 1765

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers's CLBT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 122,800 shares — an estimated $2.21M sold.

Two Sigma Advisers first reported a position in CLBT in Q2 2023 and held it in 11 quarters. The position peaked at $39.9M in Q4 2024. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 122,800 Cellebrite shares in Q1 2026, an estimated $2.21M.
  • Two Sigma Advisers first reported a position in Cellebrite in Q2 2023 and held it in 11 quarters.
  • Two Sigma Advisers's Cellebrite position peaked at $39.9M in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.